The researcher Anick Berard, from the CHU Sainte-Justine and the University of Montreal, is piloting the CAMCCO-L training program on the effects of medications taken during pregnancy. As of October 6, students will begin their training with the goal of becoming future leaders in perinatal drug research.
Guided by the principles of equity, diversity and inclusion, CAMCCO-L training is a new model of virtual learning. It offers specialized online courses, professional training activities in research including seminars on patient-oriented research, discussion forums, a summer school in drug development, not to mention the possibility of Canadian professional internships. and international with CAMCCO-L mentors.
“With the CAMCCO-L training, the next generation of scientists is offered a set of tools and activities to innovate in the field of drugs and pregnancy,” says Anick Bérard, director of the drug research unit. and pregnancy at CHU Sainte-Justine.
The first cohort of CAMCCO-L training is made up of 19 graduate and postdoctoral students, including several from visible minorities. They come from Canadian educational institutions including the universities of Montreal, Toronto, Ottawa, Manitoba and British Columbia. The CAMCCO-L Scholarship Committee has awarded five scholarships for the year 2022-2023.
It is also possible to follow the training CAMCCO-L by registering for à la carte virtual courses.
From parent to patient partner in research
The CAMCCO-L program also aims to train patient partners in perinatal research. “The presence of patient partners in research is essential and their training through CAMCCO-L will make it possible to better align future research with the needs of pregnant women”, mentions Anick Bérard, also full professor at the Faculty of Pharmacy of the University of Montreal and holder of a Tier 1 Canada Research Chair in Drugs and Pregnancy. Fathers, mothers, pregnant women and families with or without sick children can register on the CAMCCO-L website. Free and adapted training is available now and many more will be added soon. “Partner patients have an experience relating to their pregnancy that researchers need”, specifies the professor.
Medicines and pregnancy
It is estimated that 75% of pregnant women take medication during pregnancy in Canada. However, there is little data on the benefits and risks associated with their consumption for the mother and the unborn child, since pregnant women are often excluded from clinical trials.
In the absence of such studies, the interdisciplinary analysis of the consequences of taking medication on the perinatal period is essential. To take full measure of its benefits and its risks for the fetus and the mother, it is necessary to have knowledge of epidemiology, genetics, toxicology and method of causal analysis and to take advantage of artificial intelligence.
The CAMCCO-L program complements the traditional training offer designed by discipline by offering transdisciplinary and intersectoral training that will better equip the researchers of tomorrow.
We want to give thanks to the writer of this write-up for this remarkable material
Medicines and pregnancy: great start for the mother-child training platform
You can view our social media profiles here as well as other related pages herehttps://www.ai-magazine.com/related-pages/